Porsio, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 1.457
EU - Europa 425
AS - Asia 231
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 2.119
Nazione #
US - Stati Uniti d'America 1.456
IT - Italia 221
CN - Cina 145
SG - Singapore 67
IE - Irlanda 54
FI - Finlandia 52
DE - Germania 28
GB - Regno Unito 17
RU - Federazione Russa 12
SE - Svezia 10
UA - Ucraina 8
FR - Francia 7
BE - Belgio 6
IQ - Iraq 5
JP - Giappone 4
RO - Romania 4
TW - Taiwan 4
IL - Israele 3
AR - Argentina 2
CI - Costa d'Avorio 2
EU - Europa 2
PL - Polonia 2
BG - Bulgaria 1
CZ - Repubblica Ceca 1
GR - Grecia 1
HU - Ungheria 1
IN - India 1
IR - Iran 1
MX - Messico 1
UZ - Uzbekistan 1
Totale 2.119
Città #
Fairfield 213
Chandler 152
Ashburn 147
Seattle 105
Woodbridge 100
Houston 89
Wilmington 87
Cambridge 78
Palermo 67
Ann Arbor 64
Dublin 54
Singapore 49
Medford 35
Nanjing 28
Des Moines 24
Princeton 22
Altamura 19
Lawrence 16
Dearborn 15
Santa Clara 15
San Diego 14
Changsha 12
Milan 11
Shenyang 11
Boardman 10
Hebei 10
Ningbo 10
Beijing 9
Nanchang 9
Jinan 8
San Paolo di Civitate 8
New York 7
Redwood City 7
Tianjin 7
Tulsa 7
Brussels 6
Columbus 6
Jiaxing 6
Renton 6
Hangzhou 5
Lanzhou 5
Zhengzhou 5
Cagliari 4
Jacksonville 4
London 4
Redmond 4
Saint Petersburg 4
Tokyo 4
Agrigento 3
Foggia 3
Haikou 3
Ludwigshafen am Rhein 3
Napoli 3
Norwalk 3
Rome 3
Salerno 3
Taiyuan 3
Taizhou 3
Trapani 3
Washington 3
Abidjan 2
Alba 2
Atlanta 2
Bremen 2
Guangzhou 2
Kilburn 2
Moscow 2
Padova 2
Parma 2
Phoenix 2
San Giorgio Del Sannio 2
San Mateo 2
Santa Rosa 2
Urbino 2
Alessandria 1
Alessandria Della Rocca 1
Aragona 1
Budapest 1
Camburzano 1
Castelvetrano 1
Catania 1
Chiswick 1
Danvers 1
Edinburgh 1
Esslingen am Neckar 1
Forest City 1
Frankfurt Am Main 1
Frankfurt am Main 1
Hefei 1
Hounslow 1
Kunming 1
Leawood 1
Martellago 1
Mehlingen 1
Melfi 1
Milazzo 1
Modena 1
Nagold 1
Nettetal 1
New Bedfont 1
Totale 1.672
Nome #
MRI-Visible Poly(ε-caprolactone) with Controlled Contrast Agent Ratios for Enhanced Visualization in Temporary Imaging Applications 148
Polymeric nanoparticles for siRNA delivery: Production and applications 140
Galactosylated polyaspartamide copolymers for siRNA targeted delivery to hepatocellular carcinoma cells 138
PEGYLATED POLYASPARTAMIDE–POLYLACTIDE BASED NANOPARTICLES PENETRATING CYSTIC FIBROSIS ARTIFICIAL MUCUS 134
Nanometric ion pair complexes of tobramycin forming microparticles for the treatment of Pseudomonas aeruginosa infections in cystic fibrosis 133
Nanoparticles of a polyaspartamide-based brush copolymer for modified release of sorafenib: In vitro and in vivo evaluation 127
Polyanion-tobramycin nanocomplexes into functional microparticles for the treatment of Pseudomonas aeruginosa infections in cystic fibrosis 123
Drug delivery systems based on polymeric micro and nanoparticles for the treatment of cystic fibrosis 121
POLYASPARTAMIDE-POLYLACTIDE GRAFT COPOLYMERS WITH TUNABLE PROPERTIES FOR THE REALIZATION OF FLUORESCENT NANOPARTICLES FOR IMAGING 115
Toward potent antibiofilm degradable medical devices: A generic method for the antibacterial surface modification of polylactide 112
Polymeric drug delivery micelle-like nanocarriers for pulmonary administration of beclomethasone dipropionate 111
MRI-visible nanoparticles from hydrophobic gadolinium poly(ε-caprolactone) conjugates 100
Nano into Micro Formulations of Tobramycin for the Treatment of Pseudomonas aeruginosa Infections in Cystic Fibrosis 100
EVALUATION OF BIODEGRADABILITY ON POLYSPARTAMIDE-POLYLACTIC ACID BASED NANOPARTICLES BY CHEMICAL HYDROLYSIS STUDIES POLYMER DEGRADATION AND STABILITY 96
Combining inulin multifunctional polycation and magnetic nanoparticles: redox-responsive siRNA-loaded systems for magnetofection 92
Improvements in Rational Design Strategies of Inulin Derivative Polycation for siRNA Delivery 91
Mucus and Cell-Penetrating Nanoparticles Embedded in Nano-into-Micro Formulations for Pulmonary Delivery of Ivacaftor in Patients with Cystic Fibrosis 91
Inhalable nano into micro dry powders for ivacaftor delivery: the role of mannitol and cysteamine as mucus-active agents 74
DEGRADATION STUDIES OF NOVEL POLYMERIC NANOPARTICLES BASED ON AMPHIPHILIC POLYLACTIC ACID-POLYASPARTAMIDE DERIVATIVES 54
Ibuprofen containing mucus-penetrating nanoparticles as therapeutic tool for the treatment of inflammation in Cystic Fibrosis 54
Evaluation of biodegradability of novel polymeric nanoparticles based on amphiphilic polylactide-polyaspartamide derivatives. 49
PREPARAZIONE, CARATTERIZZAZIONE E STUDI DI DEGRADAZIONE CHIMICA DI NUOVI SISTEMI POLIMERICI NANOPARTICELLARI A BASE DI COPOLIMERI ANFIFILICI DI UNA α,β-POLI(N-2-IDROSSIETIL)-D,L-ASPARTAMMIDE 43
Totale 2.246
Categoria #
all - tutte 8.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.407


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020440 0 0 0 0 52 80 66 44 57 50 76 15
2020/2021241 21 17 17 18 21 6 15 21 23 35 21 26
2021/2022231 12 58 13 7 2 10 15 13 27 20 13 41
2022/2023374 33 78 6 45 42 55 17 29 44 3 18 4
2023/2024156 11 27 2 32 10 29 14 6 3 3 1 18
2024/2025115 6 40 38 29 2 0 0 0 0 0 0 0
Totale 2.246